About the Authors

Layla J. Barkal

Contributed equally to this work with: Layla J. Barkal, Erwin Berthier, Ashleigh B. Theberge

Affiliations Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America

Erwin Berthier

Contributed equally to this work with: Layla J. Barkal, Erwin Berthier, Ashleigh B. Theberge

Affiliation Department of Chemistry, University of Washington, Seattle, Washington, United States of America

Ashleigh B. Theberge

Contributed equally to this work with: Layla J. Barkal, Erwin Berthier, Ashleigh B. Theberge

Affiliations Department of Chemistry, University of Washington, Seattle, Washington, United States of America, Department of Urology, University of Washington School of Medicine, Seattle, Washington, United States of America

Nancy P. Keller

npkeller@wisc.edu (NPK); djbeebe@wisc.edu (DJB)

Affiliations Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America

David J. Beebe

npkeller@wisc.edu (NPK); djbeebe@wisc.edu (DJB)

Affiliations Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin, United States of America, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, United States of America

Competing Interests

The authors declare the following competing financial interests: DJB holds equity in Bellbrook Labs LLC, Tasso Inc., Stacks to the Future LLC, Lynx Biosciences LLC, Onexio Biosystems LLC and Salus Discovery LLC; EB has ownership in Salus Discovery LLC, Tasso Inc., and Stacks to the Future LLC; ABT has ownership in Stacks to the Future LLC.